| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Surgical Wound Infection | 6 | 2018 | 501 | 1.55 | Why? |
| Cross Infection | 17 | 2020 | 8675 | 1.38 | Why? |
| Clostridium Infections | 4 | 2018 | 595 | 1.30 | Why? |
| Hospitals, Community | 6 | 2020 | 475 | 1.17 | Why? |
| Drug Resistance, Multiple, Bacterial | 3 | 2018 | 1115 | 1.14 | Why? |
| Bacteremia | 6 | 2018 | 1372 | 1.01 | Why? |
| Disinfection | 5 | 2018 | 2912 | 0.94 | Why? |
| Catheter-Related Infections | 6 | 2018 | 381 | 0.93 | Why? |
| Anti-Bacterial Agents | 12 | 2019 | 10083 | 0.82 | Why? |
| Gram-Negative Bacterial Infections | 2 | 2015 | 398 | 0.76 | Why? |
| North Carolina | 8 | 2018 | 571 | 0.68 | Why? |
| Southeastern United States | 4 | 2018 | 141 | 0.67 | Why? |
| Risk Adjustment | 3 | 2018 | 730 | 0.67 | Why? |
| Fungemia | 1 | 2017 | 86 | 0.66 | Why? |
| Escherichia coli Proteins | 1 | 2017 | 168 | 0.63 | Why? |
| Gram-Positive Cocci | 1 | 2015 | 20 | 0.60 | Why? |
| Bacillus | 1 | 2015 | 32 | 0.60 | Why? |
| Enterococcus | 2 | 2017 | 73 | 0.59 | Why? |
| Patients' Rooms | 2 | 2018 | 675 | 0.58 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 3 | 2018 | 711 | 0.57 | Why? |
| Protective Clothing | 2 | 2021 | 468 | 0.56 | Why? |
| Ultraviolet Rays | 3 | 2018 | 1272 | 0.53 | Why? |
| Genome, Bacterial | 1 | 2017 | 446 | 0.52 | Why? |
| Drug Resistance, Bacterial | 3 | 2019 | 1414 | 0.52 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.52 | Why? |
| Bacteriological Techniques | 2 | 2017 | 239 | 0.50 | Why? |
| Enterocolitis, Pseudomembranous | 1 | 2013 | 93 | 0.50 | Why? |
| Textiles | 1 | 2017 | 458 | 0.47 | Why? |
| Staphylococcus | 2 | 2018 | 77 | 0.46 | Why? |
| beta-Lactamases | 2 | 2018 | 759 | 0.46 | Why? |
| Staphylococcal Infections | 2 | 2018 | 1099 | 0.45 | Why? |
| Community-Acquired Infections | 4 | 2017 | 2328 | 0.44 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2015 | 323 | 0.44 | Why? |
| Escherichia coli | 2 | 2018 | 1547 | 0.42 | Why? |
| Cross-Over Studies | 3 | 2018 | 867 | 0.40 | Why? |
| Blood | 1 | 2011 | 274 | 0.40 | Why? |
| Football | 2 | 2021 | 120 | 0.39 | Why? |
| Urinary Tract Infections | 2 | 2017 | 534 | 0.37 | Why? |
| Academic Medical Centers | 4 | 2019 | 3088 | 0.34 | Why? |
| Sodium Hypochlorite | 2 | 2018 | 110 | 0.33 | Why? |
| Hospitals | 9 | 2020 | 11793 | 0.33 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.33 | Why? |
| Infection Control | 8 | 2020 | 23131 | 0.32 | Why? |
| Quaternary Ammonium Compounds | 2 | 2018 | 136 | 0.32 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2013 | 861 | 0.30 | Why? |
| Basketball | 2 | 2021 | 60 | 0.27 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.27 | Why? |
| Bacteria | 3 | 2019 | 1897 | 0.26 | Why? |
| Catheterization, Central Venous | 3 | 2018 | 458 | 0.24 | Why? |
| Quality Indicators, Health Care | 2 | 2018 | 580 | 0.24 | Why? |
| Seasons | 1 | 2015 | 4071 | 0.24 | Why? |
| Guideline Adherence | 4 | 2020 | 2309 | 0.23 | Why? |
| Referral and Consultation | 1 | 2017 | 4816 | 0.22 | Why? |
| Disease Management | 2 | 2018 | 6841 | 0.21 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.20 | Why? |
| Multilocus Sequence Typing | 2 | 2017 | 264 | 0.20 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.19 | Why? |
| Bacterial Physiological Phenomena | 1 | 2018 | 31 | 0.19 | Why? |
| Central Venous Catheters | 2 | 2017 | 188 | 0.18 | Why? |
| Organosilicon Compounds | 1 | 2017 | 5 | 0.18 | Why? |
| Skin | 1 | 2011 | 2096 | 0.18 | Why? |
| Injections, Intra-Articular | 1 | 2018 | 104 | 0.18 | Why? |
| Housekeeping, Hospital | 1 | 2017 | 37 | 0.17 | Why? |
| Mycobacterium abscessus | 1 | 2017 | 31 | 0.17 | Why? |
| Colony Count, Microbial | 1 | 2017 | 177 | 0.17 | Why? |
| Disinfectants | 2 | 2018 | 1077 | 0.16 | Why? |
| Single-Blind Method | 2 | 2018 | 1283 | 0.16 | Why? |
| Equipment Contamination | 4 | 2019 | 1308 | 0.16 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2017 | 170 | 0.16 | Why? |
| Meteorology | 1 | 2017 | 114 | 0.16 | Why? |
| Clinical Studies as Topic | 1 | 2017 | 118 | 0.16 | Why? |
| Light | 1 | 2018 | 306 | 0.15 | Why? |
| Fluoroquinolones | 1 | 2017 | 235 | 0.15 | Why? |
| Sepsis | 3 | 2018 | 3517 | 0.15 | Why? |
| Automation | 1 | 2017 | 429 | 0.14 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2017 | 167 | 0.14 | Why? |
| Geography, Medical | 1 | 2017 | 537 | 0.14 | Why? |
| United States | 14 | 2021 | 46150 | 0.14 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.13 | Why? |
| Humans | 46 | 2021 | 930598 | 0.13 | Why? |
| Urinary Catheterization | 1 | 2013 | 47 | 0.13 | Why? |
| Gram-Negative Bacteria | 1 | 2018 | 473 | 0.13 | Why? |
| Environmental Microbiology | 1 | 2018 | 575 | 0.13 | Why? |
| Candida | 1 | 2017 | 425 | 0.13 | Why? |
| Radiography, Thoracic | 2 | 2020 | 5486 | 0.12 | Why? |
| Nurse Administrators | 1 | 2018 | 272 | 0.12 | Why? |
| Geographic Information Systems | 1 | 2017 | 507 | 0.12 | Why? |
| Drug Utilization | 1 | 2018 | 619 | 0.12 | Why? |
| Microbial Sensitivity Tests | 2 | 2019 | 2886 | 0.12 | Why? |
| Spine | 1 | 2015 | 292 | 0.12 | Why? |
| Antimicrobial Stewardship | 2 | 2018 | 931 | 0.12 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.11 | Why? |
| Respiratory Tract Diseases | 1 | 2020 | 1061 | 0.11 | Why? |
| Length of Stay | 3 | 2018 | 11042 | 0.11 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.11 | Why? |
| Cell Phone | 1 | 2019 | 750 | 0.11 | Why? |
| Spatial Analysis | 1 | 2017 | 878 | 0.11 | Why? |
| Geography | 1 | 2017 | 1801 | 0.11 | Why? |
| Demography | 1 | 2018 | 1660 | 0.11 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.10 | Why? |
| Interprofessional Relations | 1 | 2018 | 1013 | 0.10 | Why? |
| Pneumonia, Bacterial | 1 | 2017 | 843 | 0.10 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.09 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.09 | Why? |
| Health Resources | 1 | 2020 | 2592 | 0.08 | Why? |
| Research Personnel | 1 | 2017 | 1037 | 0.08 | Why? |
| Eye Diseases | 1 | 2017 | 1150 | 0.08 | Why? |
| Male | 16 | 2021 | 367725 | 0.08 | Why? |
| Aged | 12 | 2021 | 215776 | 0.08 | Why? |
| Inpatients | 2 | 2019 | 5161 | 0.08 | Why? |
| Occupational Diseases | 1 | 2021 | 2787 | 0.07 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Tertiary Care Centers | 3 | 2018 | 8248 | 0.07 | Why? |
| Nurses | 2 | 2019 | 2285 | 0.07 | Why? |
| Proportional Hazards Models | 2 | 2017 | 6543 | 0.07 | Why? |
| Female | 14 | 2021 | 380317 | 0.07 | Why? |
| Occupational Health | 1 | 2021 | 3965 | 0.07 | Why? |
| Epidemiological Monitoring | 1 | 2017 | 3493 | 0.07 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.07 | Why? |
| Comorbidity | 3 | 2017 | 34796 | 0.07 | Why? |
| Adult | 12 | 2021 | 244371 | 0.07 | Why? |
| Leadership | 1 | 2017 | 2241 | 0.06 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.06 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.06 | Why? |
| Intensive Care Units | 3 | 2019 | 29594 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| African Americans | 1 | 2018 | 3363 | 0.06 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.06 | Why? |
| Delphi Technique | 2 | 2017 | 1257 | 0.06 | Why? |
| Prevalence | 2 | 2015 | 25773 | 0.06 | Why? |
| Nylons | 1 | 2021 | 34 | 0.06 | Why? |
| Early Diagnosis | 2 | 2021 | 2443 | 0.06 | Why? |
| Masks | 2 | 2021 | 8528 | 0.06 | Why? |
| Practice Patterns, Physicians' | 1 | 2020 | 4927 | 0.06 | Why? |
| Time-to-Treatment | 1 | 2018 | 5883 | 0.06 | Why? |
| Polypropylenes | 1 | 2021 | 121 | 0.06 | Why? |
| Risk Factors | 7 | 2018 | 71621 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Cotton Fiber | 1 | 2021 | 61 | 0.05 | Why? |
| Polyesters | 1 | 2021 | 94 | 0.05 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.05 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.05 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.05 | Why? |
| Virus Replication | 1 | 2021 | 14331 | 0.05 | Why? |
| Coagulase | 1 | 2018 | 44 | 0.05 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 5002 | 0.05 | Why? |
| Disease Outbreaks | 2 | 2017 | 27595 | 0.05 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.04 | Why? |
| Virginia | 1 | 2018 | 228 | 0.04 | Why? |
| Urinary Catheters | 1 | 2017 | 35 | 0.04 | Why? |
| Infection Control Practitioners | 1 | 2017 | 50 | 0.04 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.04 | Why? |
| Vancomycin Resistance | 1 | 2017 | 55 | 0.04 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.04 | Why? |
| Medical Audit | 1 | 2018 | 218 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2018 | 673 | 0.04 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.04 | Why? |
| Patient Care Bundles | 1 | 2018 | 137 | 0.04 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2017 | 104 | 0.04 | Why? |
| Genes, Bacterial | 1 | 2017 | 207 | 0.04 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.04 | Why? |
| Personal Protective Equipment | 4 | 2021 | 15978 | 0.04 | Why? |
| Gloves, Protective | 1 | 2017 | 249 | 0.04 | Why? |
| Filtration | 1 | 2021 | 820 | 0.04 | Why? |
| Microbial Viability | 1 | 2018 | 406 | 0.04 | Why? |
| Stem Cell Transplantation | 1 | 2020 | 531 | 0.03 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.03 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.03 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.03 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.03 | Why? |
| Video Recording | 1 | 2020 | 786 | 0.03 | Why? |
| Consensus | 2 | 2020 | 6345 | 0.03 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.03 | Why? |
| Ventilation | 1 | 2021 | 1145 | 0.03 | Why? |
| Quality Assurance, Health Care | 1 | 2018 | 596 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Athletes | 1 | 2021 | 1047 | 0.03 | Why? |
| Specimen Handling | 1 | 2011 | 6190 | 0.03 | Why? |
| Fomites | 1 | 2019 | 709 | 0.03 | Why? |
| Arthroplasty, Replacement, Knee | 1 | 2018 | 363 | 0.03 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2018 | 403 | 0.03 | Why? |
| Bias | 1 | 2018 | 1109 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2018 | 88759 | 0.03 | Why? |
| Health Care Surveys | 1 | 2020 | 2942 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Pain | 1 | 2018 | 1084 | 0.03 | Why? |
| Equipment Design | 1 | 2021 | 3095 | 0.03 | Why? |
| Feasibility Studies | 1 | 2019 | 3467 | 0.02 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.02 | Why? |
| Hospitalization | 1 | 2019 | 54280 | 0.02 | Why? |
| Patient Readmission | 1 | 2017 | 1543 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Treatment Outcome | 1 | 2013 | 51732 | 0.02 | Why? |
| Hand Hygiene | 1 | 2017 | 1493 | 0.02 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.02 | Why? |
| Hospitals, University | 1 | 2019 | 4173 | 0.02 | Why? |
| Electronic Health Records | 1 | 2019 | 3492 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Carrier State | 1 | 2017 | 2100 | 0.02 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.02 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.02 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.02 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Communication | 1 | 2017 | 5206 | 0.01 | Why? |
| Venous Thromboembolism | 1 | 2017 | 4273 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2018 | 14232 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |